Background Recent research suggests that baseline body mass index (BMI) is associated
with response to immunotherapy. In this study, we test the hypothesis that worsening …

Simple Summary Tumors of head and neck cancer are a heterogenous collection of
malignancies affecting the upper aerodigestive tract, the majority of which are head and …

Introduction Association of high body mass index (BMI) with longer survival has been
reported in patients on immune checkpoint inhibitors (ICIs), but results are inconsistent. This …

Background This systematic review and meta-analysis aimed to evaluate the association
between pretreatment body mass index (BMI) and clinical outcomes in cancer patients …

Methods In this international multicenter study, we evaluated the association between
baseline BMI, progression-free survival (PFS) and overall survival (OS) in a cohort of …

Despite major improvements in combatting metastatic melanoma since the advent of
immunotherapy, the overall survival for patients with advanced disease remains low …

Background Body mass index (BMI) is used to define obesity, but it is an imperfect measure
of body composition. In the current study, the authors explored the association between …

Objective Recent studies suggest obesity is associated with improved survival of cancer
patients treated with immune checkpoint inhibitors (ICIs). We performed this meta-analysis to …

Objective To investigate the association between pretreatment prognostic nutritional index
(PNI) and clinical survival outcomes for advanced-stage cancer patients treated with …

Background A male gender driven obesity paradox (improved survival for overweight/obese
patients compared to normal weight) was recently shown in melanoma in the context of …